Published

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychopharmacology
Date: 2011-12-01
Source: PubMed
DOI: 10.1007/s00213-011-2358-5
PubMed: 21674151

Authors

Griffiths RR Johnson MW Richards WA Richards BD McCann U Jesse R

Watch author

Derived topics and classifications

psilocybin Anxiety Spirituality Mystical Experience Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 13 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study2026-08-01 Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial2026-07-30 Longitudinal neural and psychological changes following psilocybin under compassion imagery priming2026-07-22 Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01 Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression2026-05-01 Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review2026-03-09 “Diversity makes the richness of humanity”: The emergence and persistence of mental imagery after self-reported psilocybin truffles intake in an autistic woman with “blind imagination” (aphantasia): A33-month retrospective case report2026-03-09 Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01 Pilot study of psilocybin in patients with post-treatment lyme disease2026-02-25 Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience2021-09-01 DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin2016-06-01 Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol2013-08-01 Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.2011-12-01

Related papers

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.Psychopharmacology · 2012-09-01 Identifying Three Psilocybin Use Patterns by Frequency and Quantity.Journal of studies on alcohol and drugs · 2025-05-01 Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitionersJournal of Psychedelic Studies · 2025-02-05 Exploring the first use of psychedelic macrodoses in Latin American adults: Sociodemographic profiles, consumption factors, and subjective experiencesJournal of Psychedelic Studies · 2025-11-20 Beyond prohibition: A public health analysis of naturalistic psychedelic useJournal of Psychedelic Studies · 2025-07-03 Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapyJournal of Psychedelic Studies · 2023-08-21 Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serumJournal of Psychedelic Studies · 2022-12-07 Classic psychedelic medicines for adolescent refractory mental health diseaseJournal of Psychedelic Studies · 2026-03-26